Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands | Acute Coronary Syndromes | JAMA Network Open | JAMA Network
[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.234.207.100. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Eijsvogels  TM, Molossi  S, Lee  DC, Emery  MS, Thompson  PD.  Exercise at the extremes: the amount of exercise to reduce cardiovascular events.   J Am Coll Cardiol. 2016;67(3):316-329. doi:10.1016/j.jacc.2015.11.034 PubMedGoogle ScholarCrossref
2.
Heran  BS, Chen  JM, Ebrahim  S,  et al.  Exercise-based cardiac rehabilitation for coronary heart disease.   Cochrane Database Syst Rev. 2011;(7):CD001800. doi:10.1002/14651858.CD001800.pub2 PubMedGoogle Scholar
3.
Lawler  PR, Filion  KB, Eisenberg  MJ.  Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.   Am Heart J. 2011;162(4):571-584.e2. doi:10.1016/j.ahj.2011.07.017 PubMedGoogle ScholarCrossref
4.
Taylor  RS, Sagar  VA, Davies  EJ,  et al.  Exercise-based rehabilitation for heart failure.   Cochrane Database Syst Rev. 2014;4(4):CD003331. doi:10.1002/14651858.CD003331.pub4PubMedGoogle Scholar
5.
Anderson  L, Oldridge  N, Thompson  DR,  et al.  Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis.   J Am Coll Cardiol. 2016;67(1):1-12. doi:10.1016/j.jacc.2015.10.044 PubMedGoogle ScholarCrossref
6.
Lewinter  C, Doherty  P, Gale  CP,  et al.  Exercise-based cardiac rehabilitation in patients with heart failure: a meta-analysis of randomised controlled trials between 1999 and 2013.   Eur J Prev Cardiol. 2015;22(12):1504-1512. doi:10.1177/2047487314559853 PubMedGoogle ScholarCrossref
7.
Piepoli  MF, Hoes  AW, Agewall  S,  et al; ESC Scientific Document Group.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).   Eur Heart J. 2016;37(29):2315-2381. doi:10.1093/eurheartj/ehw106 PubMedGoogle ScholarCrossref
8.
Amsterdam  EA, Wenger  NK, Brindis  RG,  et al; ACC/AHA Task Force Members.  2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;130(25):e433-e434].   Circulation. 2014;130(25):e344-e426.PubMedGoogle Scholar
9.
O’Gara  PT, Kushner  FG, Ascheim  DD,  et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.   Circulation. 2013;127(4):e362-e425. doi:10.1161/CIR.0b013e3182742c84 PubMedGoogle ScholarCrossref
10.
Fihn  SD, Gardin  JM, Abrams  J,  et al; American College of Cardiology Foundation.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [published correction appears in Circulation. 2014;129(16):e462].   Circulation. 2012;126(25):3097-3137. doi:10.1161/CIR.0b013e3182776f83 PubMedGoogle ScholarCrossref
11.
Golwala  H, Pandey  A, Ju  C,  et al.  Temporal trends and factors associated with cardiac rehabilitation referral among patients hospitalized with heart failure: findings from Get With the Guidelines–Heart Failure registry.   J Am Coll Cardiol. 2015;66(8):917-926. doi:10.1016/j.jacc.2015.06.1089 PubMedGoogle ScholarCrossref
12.
Beatty  AL, Truong  M, Schopfer  DW, Shen  H, Bachmann  JM, Whooley  MA.  Geographic variation in cardiac rehabilitation participation in Medicare and Veterans Affairs populations: opportunity for improvement.   Circulation. 2018;137(18):1899-1908. doi:10.1161/CIRCULATIONAHA.117.029471 PubMedGoogle ScholarCrossref
13.
Doll  JA, Hellkamp  A, Ho  PM,  et al.  Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction.   JAMA Intern Med. 2015;175(10):1700-1702. doi:10.1001/jamainternmed.2015.3819 PubMedGoogle ScholarCrossref
14.
Sukul  D, Seth  M, Barnes  GD,  et al.  Cardiac rehabilitation use after percutaneous coronary intervention.   J Am Coll Cardiol. 2019;73(24):3148-3152. doi:10.1016/j.jacc.2019.03.515 PubMedGoogle ScholarCrossref
15.
Statistics Netherlands. Population counter. Published May 25, 2020. Accessed June 16, 2020. https://www.cbs.nl/en-gb/visualisaties/population-counter
16.
Revalidatiecommissie Nederlandse Vereniging Voor Cardiologie/Nederlandse Hartstichting (Richtlijn Hartrevalidatie 2004), Projectgroep PAAHR (gedeeltelijke herziening 2011). Multidisciplinary Cardiac Rehabilitation Guideline [in Dutch]. Nederlandse Vereniging Voor Cardiologie; 2011.
17.
Sandesara  PB, Lambert  CT, Gordon  NF,  et al.  Cardiac rehabilitation and risk reduction: time to “rebrand and reinvigorate.”   J Am Coll Cardiol. 2015;65(4):389-395. doi:10.1016/j.jacc.2014.10.059 PubMedGoogle ScholarCrossref
18.
Balady  GJ, Williams  MA, Ades  PA,  et al; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Association of Cardiovascular and Pulmonary Rehabilitation.  Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.   Circulation. 2007;115(20):2675-2682. doi:10.1161/CIRCULATIONAHA.106.180945 PubMedGoogle ScholarCrossref
19.
Goud  R, de Keizer  NF, ter Riet  G,  et al.  Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation.   BMJ. 2009;338:b1440. doi:10.1136/bmj.b1440 PubMedGoogle ScholarCrossref
20.
de Vries  H, Kemps  HM, van Engen-Verheul  MM, Kraaijenhagen  RA, Peek  N.  Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients.   Eur Heart J. 2015;36(24):1519-1528. doi:10.1093/eurheartj/ehv111 PubMedGoogle ScholarCrossref
21.
Martin  BJ, Hauer  T, Arena  R,  et al.  Cardiac rehabilitation attendance and outcomes in coronary artery disease patients.   Circulation. 2012;126(6):677-687. doi:10.1161/CIRCULATIONAHA.111.066738 PubMedGoogle ScholarCrossref
22.
Huber  CA, Szucs  TD, Rapold  R, Reich  O.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.   BMC Public Health. 2013;13:1030. doi:10.1186/1471-2458-13-1030 PubMedGoogle ScholarCrossref
23.
Quan  H, Li  B, Couris  CM,  et al.  Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.   Am J Epidemiol. 2011;173(6):676-682. doi:10.1093/aje/kwq433 PubMedGoogle ScholarCrossref
24.
Xu  S, Ross  C, Raebel  MA, Shetterly  S, Blanchette  C, Smith  D.  Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.   Value Health. 2010;13(2):273-277. doi:10.1111/j.1524-4733.2009.00671.x PubMedGoogle ScholarCrossref
25.
Okoli  GN, Sanders  RD, Myles  P.  Demystifying propensity scores.   Br J Anaesth. 2014;112(1):13-15. doi:10.1093/bja/aet290 PubMedGoogle ScholarCrossref
26.
Stürmer  T, Rothman  KJ, Glynn  RJ.  Insights into different results from different causal contrasts in the presence of effect-measure modification.   Pharmacoepidemiol Drug Saf. 2006;15(10):698-709. doi:10.1002/pds.1231 PubMedGoogle ScholarCrossref
27.
Long  L, Mordi  IR, Bridges  C,  et al.  Exercise-based cardiac rehabilitation for adults with heart failure.   Cochrane Database Syst Rev. 2019;1:CD003331. doi:10.1002/14651858.CD003331.pub5 PubMedGoogle Scholar
28.
Long  L, Anderson  L, Dewhirst  AM,  et al.  Exercise-based cardiac rehabilitation for adults with stable angina.   Cochrane Database Syst Rev. 2018;2:CD012786. doi:10.1002/14651858.CD012786.pub2 PubMedGoogle Scholar
29.
Slack  MK, Draugalis  JR.  Establishing the internal and external validity of experimental studies.   Am J Health Syst Pharm. 2001;58(22):2173-2181. doi:10.1093/ajhp/58.22.2173 PubMedGoogle ScholarCrossref
30.
Müller-Riemenschneider  F, Meinhard  C, Damm  K,  et al.  Effectiveness of nonpharmacological secondary prevention of coronary heart disease.   Eur J Cardiovasc Prev Rehabil. 2010;17(6):688-700. doi:10.1097/HJR.0b013e32833a1c95 PubMedGoogle ScholarCrossref
31.
Patel  DK, Duncan  MS, Shah  AS,  et al.  Association of cardiac rehabilitation with decreased hospitalization and mortality risk after cardiac valve surgery.   JAMA Cardiol. 2019;4(12):1250-1259. doi:10.1001/jamacardio.2019.4032 PubMedGoogle ScholarCrossref
32.
Beatty  AL, Doll  JA, Schopfer  DW,  et al.  Cardiac rehabilitation participation and mortality after percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.   J Am Heart Assoc. 2018;7(19):e010010. doi:10.1161/JAHA.118.010010 PubMedGoogle Scholar
33.
Ghisi  GLM, Chaves  GSDS, Bennett  A, Lavie  CJ, Grace  SL.  The effects of cardiac rehabilitation on mortality and morbidity in women: a meta-analysis attempt.   J Cardiopulm Rehabil Prev. 2019;39(1):39-42. doi:10.1097/HCR.0000000000000351 PubMedGoogle ScholarCrossref
34.
Deaton  C.  Addressing the paradox of age and participation in cardiac rehabilitation.   Eur J Prev Cardiol. 2019;26(10):1050-1051. doi:10.1177/2047487319839258 PubMedGoogle ScholarCrossref
35.
Rich  MW, Chyun  DA, Skolnick  AH,  et al; American Heart Association Older Populations Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council; American College of Cardiology; and American Geriatrics Society.  Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society.   Circulation. 2016;133(21):2103-2122. doi:10.1161/CIR.0000000000000380 PubMedGoogle ScholarCrossref
36.
Forman  DE, Maurer  MS, Boyd  C,  et al.  Multimorbidity in older adults with cardiovascular disease.   J Am Coll Cardiol. 2018;71(19):2149-2161. doi:10.1016/j.jacc.2018.03.022 PubMedGoogle ScholarCrossref
37.
Canivell  S, Muller  O, Gencer  B,  et al.  Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.   PLoS One. 2018;13(4):e0195174. doi:10.1371/journal.pone.0195174 PubMedGoogle Scholar
38.
Brown  TM, Hernandez  AF, Bittner  V,  et al; American Heart Association Get With the Guidelines Investigators.  Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association’s Get With the Guidelines program.   J Am Coll Cardiol. 2009;54(6):515-521. doi:10.1016/j.jacc.2009.02.080 PubMedGoogle ScholarCrossref
39.
Kotseva  K, Wood  D, De Bacquer  D; EUROASPIRE Investigators.  Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.   Eur J Prev Cardiol. 2018;25(12):1242-1251. doi:10.1177/2047487318781359 PubMedGoogle ScholarCrossref
40.
Kotseva  K, Wood  D, De Backer  G, De Bacquer  D; EUROASPIRE III Study Group.  Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey.   Eur J Prev Cardiol. 2013;20(5):817-826. doi:10.1177/2047487312449591 PubMedGoogle ScholarCrossref
41.
Neumann  FJ, Sousa-Uva  M, Ahlsson  A,  et al; ESC Scientific Document Group.  2018 ESC/EACTS Guidelines on myocardial revascularization [published correction appears in Eur Heart J. 2019;40(37):3096].   Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394 PubMedGoogle ScholarCrossref
42.
Schopfer  DW, Forman  DE.  Cardiac rehabilitation in older adults.   Can J Cardiol. 2016;32(9):1088-1096. doi:10.1016/j.cjca.2016.03.003 PubMedGoogle ScholarCrossref
43.
Anderson  L, Sharp  GA, Norton  RJ,  et al.  Home-based versus centre-based cardiac rehabilitation.   Cochrane Database Syst Rev. 2017;6:CD007130. doi:10.1002/14651858.CD007130.pub4PubMedGoogle Scholar
44.
Thomas  RJ, Beatty  AL, Beckie  TM,  et al.  Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.   Circulation. 2019;140(1):e69-e89. doi:10.1161/CIR.0000000000000663 PubMedGoogle ScholarCrossref
45.
Frederix  I, Vanhees  L, Dendale  P, Goetschalckx  K.  A review of telerehabilitation for cardiac patients.   J Telemed Telecare. 2015;21(1):45-53. doi:10.1177/1357633X14562732 PubMedGoogle ScholarCrossref
46.
Saner  H, van der Velde  E.  eHealth in cardiovascular medicine: a clinical update.   Eur J Prev Cardiol. 2016;23(2)(suppl):5-12. doi:10.1177/2047487316670256 PubMedGoogle ScholarCrossref
47.
Statistics Netherlands. Ethnic groups in the Netherlands. Bevolking naar migratieachtergrond. Published November 21, 2016. Accessed June 16, 2020. https://www.cbs.nl/nl-nl/achtergrond/2016/47/bevolking-naar-migratieachtergrond
48.
Smeets  HM, de Wit  NJ, Hoes  AW.  Routine health insurance data for scientific research: potential and limitations of the Agis Health Database.   J Clin Epidemiol. 2011;64(4):424-430. doi:10.1016/j.jclinepi.2010.04.023 PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 5,063
    Citations 0
    Original Investigation
    Cardiology
    July 27, 2020

    Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands

    Author Affiliations
    • 1Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands
    • 2Coöperatie Volksgezondheidszorg, Business Intelligence Services, Arnhem, the Netherlands
    • 3Research Institute for Sports and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom
    • 4Department of Cardiology, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands
    • 5Division of Cardiology, Hartford Hospital, Hartford, Connecticut
    JAMA Netw Open. 2020;3(7):e2011686. doi:10.1001/jamanetworkopen.2020.11686
    Key Points español 中文 (chinese)

    Question  What is the patient-specific, disease-specific, and comorbidity-specific association of cardiac rehabilitation participation with all-cause mortality?

    Findings  In this cohort study, 31% of 83 687 eligible patients with cardiovascular disease participated in a multidisciplinary outpatient cardiac rehabilitation program. Cardiac rehabilitation participation was associated with a 32% lower risk of all-cause mortality compared with nonparticipation, which was independent of patient-related and comorbidity-related characteristics.

    Meaning  Cardiac rehabilitation participation is associated with a lower mortality risk compared with nonparticipation; however, cardiac rehabilitation remains underused, especially in older adults with chronic diseases or multimorbidity.

    Abstract

    Importance  Cardiac rehabilitation (CR) is an effective strategy to improve clinical outcomes, but it remains underused in some subgroups of patients with cardiovascular disease (CVD).

    Objective  To investigate the implications of sex, age, socioeconomic status, CVD diagnosis, cardiothoracic surgery, and comorbidity for the association between CR participation and all-cause mortality.

    Design, Setting, and Participants  Observational cohort study with patient enrollment between July 1, 2012, and December 31, 2017, and a follow-up to March 19, 2020. The dates of analysis were March to May 2020. This study was performed among Dutch patients with CVD with a multidisciplinary outpatient CR program indication and who were insured at Coöperatie Volksgezondheidszorg, one of the largest health insurance companies in the Netherlands. Among 4.1 million beneficiaries, patients with CVD with an acute coronary event (myocardial infarction or unstable angina pectoris), stable angina pectoris, chronic heart failure, or cardiothoracic surgery (coronary artery bypass grafting, valve replacement, or percutaneous coronary intervention) were identified by inpatient diagnosis codes and included in the study.

    Main Outcomes and Measures  Cox proportional hazards models were used to evaluate the association between CR participation and all-cause mortality. Stabilized inverse propensity score weighting was used to account for patient and disease characteristics associated with CR participation.

    Results  Among 83 687 eligible patients with CVD (mean [SD] age, 67 [12] years; 60.4% [n = 50 512] men), only 31.3% (n = 26 171) participated in CR, with large variation across different subgroups (range, 5.1%-73.0%). During a mean (SD) of 4.7 (1.8) years of follow-up, 1966 CR participants (7.5%) and 13 443 CR nonparticipants (23.4%) died. After multivariable adjustment, CR participation was associated with a 32% lower risk of all-cause mortality (adjusted hazard ratio, 0.68; 95% CI, 0.65-0.71) compared with nonparticipation. Sex, age, socioeconomic status, and comorbidity did not alter risk reduction after CR participation, but a statistically significant interaction association was found across categories of CVD diagnosis and cardiothoracic surgery. Larger reductions in risk estimates for all-cause mortality were found after CR participation for STEMI (adjusted HR, 0.59; 95% CI, 0.52-0.68 vs 0.72; 95% CI, 0.65-0.79; P < .001), NSTEMI (adjusted HR, 0.64; 95% CI, 0.58-0.70 vs 0.72; 95% CI, 0.65-0.79; P < .001), and stable AP (adjusted HR, 0.69; 95% CI, 0.63-0.76 vs 0.72; 95% CI, 0.65-0.79; P < .001) compared with patients with chronic heart failure, whereas unstable AP had a smaller risk reduction (adjusted HR, 0.75; 95% CI, 0.67-0.85 vs 0.72; 95% CI, 0.65-0.79; P < .001).

    Conclusions and Relevance  In this cohort study, CR participation was associated with a 32% risk reduction in all-cause mortality, and this benefit was independent of sex, age, socioeconomic status, and comorbidity. These findings reinforce the importance of CR participation in secondary prevention and highlight the possibility that CR should be prescribed more widely to vulnerable patients with CVD, such as older adults with chronic diseases or multimorbidity.

    ×